J L Abelson
Overview
Explore the profile of J L Abelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Ast V, Spicer J, Smith E, Schmer-Galunder S, Liberzon I, Abelson J, et al.
Cereb Cortex
. 2014 Sep;
26(2):544-556.
PMID: 25249408
Social threat can have adverse effects on cognitive performance, but the brain mechanisms underlying its effects are poorly understood. We investigated the effects of social evaluative threat on working memory...
2.
Abelson J, Young E
Psychoneuroendocrinology
. 2003 Jan;
28(2):169-80.
PMID: 12510010
Intravenous injection of the cholecystokinin (CCK)-B receptor agonist, pentagastrin, produces robust, dose-dependent release of adrenocorticotropin (ACTH) and cortisol, supporting the hypothesis that CCK-B agonists pharmacologically activate the hypothalamic-pituitary-adrenal (HPA) axis....
3.
Abelson J, Weg J, Nesse R, Curtis G
Biol Psychiatry
. 2001 Apr;
49(7):588-95.
PMID: 11297716
Background: Dysregulated respiratory control may play a role in the pathophysiology of panic disorder. This could be due to abnormalities in brain stem respiratory nuclei or to dysregulation at higher...
4.
Rajarethinam R, Abelson J, Himle J
Depress Anxiety
. 2001 Feb;
12(4):238-40.
PMID: 11195761
Obsessive Compulsive Disorder (OCD) is generally chronic. Episodic OCD with complete remission has been rarely reported. Two cases of brief, episodic obsessions and compulsions that appeared for the first time...
5.
Abelson J, Le Melledo J, Bichet D
Neuropsychopharmacology
. 2000 Dec;
24(2):161-9.
PMID: 11120398
Cholecystokinin (CCK) is a peptide neurotransmitter that modulates hypothalamic-pituitary-adrenal (HPA) axis activity and may be involved in fear or anxiety states. Arginine vasopressin (AVP) also modulates HPA axis activity and...
6.
Abelson J, Liberzon I
Neuropsychopharmacology
. 1999 Sep;
21(4):485-94.
PMID: 10481831
Cholecystokinin (CCK) is an abundant neurotransmitter in brain. Its functional significance in humans is incompletely understood, but it may modulate activity in the hypothalamic-pituitary-adrenal (HPA) axis. To explore this hypothesis,...
7.
Himle J, Abelson J, Haghightgou H, Hill E, Nesse R, Curtis G
Am J Psychiatry
. 1999 Aug;
156(8):1237-43.
PMID: 10450266
Objective: Previous research has demonstrated a greater-than-expected association between social phobia and alcohol use disorders. The purpose of this study was to test the hypothesis that drinking alcohol reduces social...
8.
Liberzon I, Abelson J, Flagel S, Raz J, Young E
Neuropsychopharmacology
. 1999 Jun;
21(1):40-50.
PMID: 10379518
Biological research on post-traumatic stress disorder (PTSD) has focused on autonomic, sympatho-adrenal, and hypothalamo-pituitary-adrenal (HPA) axis systems. Interactions among these response modalities have not been well studied and may be...
9.
Huang M, Rajarethinam R, Abelson J, Alessi N
MD Comput
. 1998 Jul;
15(4):238-41.
PMID: 9673088
No abstract available.
10.
Albucher R, Abelson J, Nesse R
Am J Psychiatry
. 1998 Apr;
155(4):558-9.
PMID: 9546006
Objective: Changes in defense mechanisms after treatment of patients with obsessive-compulsive disorder (OCD) were measured by using an established rating scale. Method: Before and after 7-week group behavior therapy, 17...